Aligos Therapeutics Inc
NASDAQ:ALGS
Aligos Therapeutics Inc
NASDAQ:ALGS
Price:
5.28
USD
2.33%
Market Cap:
$32.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aligos Therapeutics Inc
NASDAQ:ALGS
|
US |
|
Siemens AG
XETRA:SIE
|
DE |
|
Enad Global 7 AB (publ)
STO:EG7
|
SE |
|
V
|
Vidrala SA
XBER:VIR
|
ES |
|
Kuros Biosciences AG
SIX:KURN
|
CH |
|
S
|
Stef SA
PAR:STF
|
FR |
|
G
|
Gap Inc
XBER:GAP
|
US |
|
Home Depot Inc
NYSE:HD
|
US |
|
C
|
Cohen Development Gas & Oil Ltd
TASE:CDEV
|
IL |
|
Beeline Holdings Inc
NASDAQ:BLNE
|
US |
|
UGI Corp
NYSE:UGI
|
US |
|
Aiful Corp
TSE:8515
|
JP |
|
XSpray Pharma AB (publ)
STO:XSPRAY
|
SE |
|
P
|
Public Storage
SWB:PUP
|
US |
|
Sun Frontier Fudousan Co Ltd
TSE:8934
|
JP |
|
Daily Journal Corp
NASDAQ:DJCO
|
US |
|
BHP Group Ltd
ASX:BHP
|
AU |
Multiples-Based Value
The Multiples-Based Value for Aligos Therapeutics Inc (ALGS) under the Base Case is hidden
USD.
Compared with the current market price of 5.28 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALGS Multiples-Based Value
LOCKED
